0000899866-20-000098.txt : 20201221 0000899866-20-000098.hdr.sgml : 20201221 20201221170035 ACCESSION NUMBER: 0000899866-20-000098 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201217 FILED AS OF DATE: 20201221 DATE AS OF CHANGE: 20201221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bazarko Daniel CENTRAL INDEX KEY: 0001768214 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 201404915 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS, INC. STREET 2: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 4752302596 MAIL ADDRESS: STREET 1: 121 SEAPORT BOULEVARD CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: ALEXION PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960111 4 1 wf-form4_160858802064948.xml FORM 4 X0306 4 2020-12-17 0 0000899866 ALEXION PHARMACEUTICALS, INC. ALXN 0001768214 Bazarko Daniel C/O ALEXION PHARMACEUTICALS, INC. 121 SEAPORT BOULEVARD BOSTON MA 02210 0 1 0 0 SVP, Controller, CAO Common Stock, par value $.0001 per share 2020-12-17 4 M 0 13066 97.58 A 43949 D Common Stock, par value $.0001 per share 2020-12-17 4 M 0 11000 140.16 A 54949 D Common Stock, par value $.0001 per share 2020-12-17 4 S 0 9900 157.59 D 45049 D Common Stock, par value $.0001 per share 2020-12-17 4 S 0 13066 157.76 D 31983 D Common Stock, par value $.0001 per share 2020-12-17 4 S 0 1100 158 D 30883 D Common Stock 97.58 2020-12-17 4 M 0 13066 0 D 2023-06-01 Common Stock, par value $.0001 per share 13066.0 0 D Common Stock 140.16 2020-12-17 4 M 0 11000 0 D 2026-02-28 Common Stock, par value $.0001 per share 11000.0 0 D This transaction was executed in multiple trades through a broker-dealer at prices ranging from $157.75 - $157.79. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. Beginning June 1, 2013, options became exercisable 25% after one year and 1/16 every three months thereafter until fully vested over 4 years. Beginning February 26, 2016, options became exercisable 25% after one year and 1/16 every three months thereafter until fully vested over 4 years. /s/ Douglas Barry, Attorney-in-Fact for Daniel Bazarko 2020-12-21